Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Group International Regulatory News (ALPH)

Share Price Information for Alpha Group International (ALPH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,400.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 30.00 (1.245%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,400.00
ALPH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re: application for Main Market admission

17 Apr 2024 14:55

RNS Number : 0169L
Alpha Group International PLC
17 April 2024
 

17 April 2024

Alpha Group International plc

 

("Alpha" or the "Group") 

 

Update re application for admission to the Main Market and cancellation of trading on AIM

 

Alpha Group International plc, (AIM: ALPH), a high-tech, high-touch provider of financial solutions, dedicated to corporates and institutions operating internationally, announces that, further to its announcement of 3 April 2024, it expects that its ordinary shares will be admitted to the premium listing segment of the Official List and to be traded on the main market for listed securities (the "Main Market") of the London Stock Exchange plc (the "London Stock Exchange") ("Admission") and that the Company's listing on AIM will be cancelled on 2 May 2024.

 

Admission remains subject to (i) the approval by the FCA of a Prospectus and admission to the premium listing segment of the Official List; and (ii) admission by the London Stock Exchange to trading of the ordinary shares on the Main Market. Further announcements will be made in due course.

 

Enquiries:

 

Alpha Group International plc

Morgan Tillbrook, Founder and CEO

Tim Powell, CFO

Via Alma

 

 

Liberum (Nominated Adviser and Joint Broker)

Max Jones

Ben Cryer

Anake Singh

 

+44 (0) 20 3100 2000

 

 

Peel Hunt (Joint Broker)

Neil Patel

Paul Gillam

Kate Bannatyne

 

+44 (0) 20 7418 8900

 

Alma Strategic Communications

(Financial Public Relations)

Josh Royston

Andy Bryant

Kieran Breheny

 

+44 (0) 20 3405 0205

 

Notes to editors

Alpha is a high-tech, high-touch provider of enhanced financial solutions dedicated to corporates and institutions globally. Working with clients across 50+ countries, we blend intelligent human capabilities with new technologies to provide clients with an enhanced alternative to their bank, with solutions covering: FX risk management, global accounts mass payments, fund finance and bank management.

 

Key to our success is our team - over 400 people based across seven global offices, brought together by a high-performance culture and a partnership structure that empowers them to act as owners of our business.

 

Whilst we are an established business listed on the London Stock Exchange, we remain relentlessly focused on maintaining the same level of operational agility and client focus we had when we first started in 2009. This dynamic, combined with the passion of our people, have enabled us to make a substantial and enduring difference to our clients, and deliver a growth story to match.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPURCCUPCGWM
Date   Source Headline
3rd Apr 20247:00 amRNSIntended application for admission to Main Market
2nd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:30 amRNSTransfer of Shares from Treasury
26th Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:01 amRNSBoard Changes
20th Mar 20247:00 amRNSFull Year Results
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20241:50 pmRNSHolding(s) in Company
16th Feb 20241:43 pmRNSHolding(s) in Company
16th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSShare Buyback Programme
18th Jan 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSCompletion of Cobase Acquisition
29th Sep 20237:00 amRNSResult of Secondary Placing of Ordinary Shares
28th Sep 20235:17 pmRNSDirector/PDMR Dealing
28th Sep 20235:15 pmRNSProposed Secondary Placing of Ordinary Shares
21st Sep 20237:00 amRNSUpdate on Move Up to Main Market
13th Sep 20237:00 amRNSInterim Report
12th Sep 20237:00 amRNSAcquisition of Cobase
9th Aug 20234:09 pmRNSHolding(s) in Company
25th Jul 20237:01 amRNSAppointment of Joint Corporate Broker
25th Jul 20237:00 amRNSTrading Update
7th Jun 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.